IMV Inc.

  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific & Clinical Advisors
    • Partnerships
  • The DPX Platform
    • Overview
    • Scientific Publications & Posters
  • Clinical Pipeline
    • Overview
    • DPX-Survivac
    • DPX-RSV
    • DPX-COVID-19
    • Clinical Trials
  • News & Events
    • Press Releases
    • Events
    • Email Alerts
  • Investors
    • Overview
    • Press Releases
    • Events, Webcasts & Presentations
    • Financial Info
    • Stock Data
    • Filings
    • Governance
    • Contact Us
    • FAQ
  • Careers
    • Overview
    • Life at IMV
  • Contact

Press Releases

Investors

Investors

  • Overview
  • Press Releases
  • Events, Webcasts & Presentations
    • Overview
    • Presentations
    • Scientific Publications & Posters
    • Email Alerts
  • Financial Info
    • Financial Results
    • Tax Info
    • Proxy Info
    • Stock Option Plan
    • Deferred Share Unit Plan
  • Stock Data
    • NASDAQ: IMV
    • TSX: IMV
    • Analyst Coverage
  • Filings
    • SEC Filings
    • SEDAR
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Contact Us
  • FAQ
Jul 26, 2019 4:00pm EDT

IMV Inc. to Present at the Canaccord Genuity 39th Annual Growth Conference

Jul 25, 2019 3:22pm EDT

IMV Inc. to Announce Second Quarter 2019 Results and Host a Conference Call and Webcast on August 9, 2019

Jun 13, 2019 5:08pm EDT

IMV Inc. to Present at Two Upcoming Investor Conferences

Jun 04, 2019 7:05am EDT

IMV Inc. to Provide Update on Phase 2 Clinical Results with Merck Keytruda in DLBCL by Means of Conference Call and Webcast on June 12, 2019

Jun 01, 2019 2:15pm EDT

IMV Inc. Presents New Positive Data from Phase 2 Monotherapy Arm of Its Decide1 Trial in Advanced Ovarian Cancer and Continued Duration of Clinical Benefits to Patients with Progression Free Survival

May 16, 2019 7:05am EDT

IMV to Present New Data at 2019 ASCO Annual Meeting From Its Phase 2 Clinical Trial Evaluating DPX-Survivac in Ovarian Cancer

May 14, 2019 5:05pm EDT

IMV Inc. to Present at Upcoming Investor Conferences

May 10, 2019 10:18am EDT

IMV Announces Annual and Special Meeting of Shareholders Voting Results

May 09, 2019 5:05pm EDT

IMV Inc. Announces Q1 2019 Financial Results and Clinical Program Advances

May 08, 2019 7:05am EDT

IMV Joins World Ovarian Cancer Coalition and Ovarian Cancer Canada in Supporting Ovarian Cancer Day 2019

RSS
  • Prev
  • 1...
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • ...35
  • Next
  • Email Alerts
  • Contacts
  • RSS News Feed
IMV Inc.
About Us The DPX Platform Clinical Pipeline News & Events Investors Careers Contact
Twitter LinkedIn Youtube
© 2021 IMV Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap